3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
5
Thoracic
1
Gynecologic
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Primary Myelofibrosis
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Interventions
pembrolizumab
8
Oxaliplatin
7
Surveys and Questionnaires
5
Methods
5
Early Intervention, Educational
5
Cyclophosphamide
5
Cisplatin
5
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Gemcitabine
4
Fluorouracil
4
Carboplatin
4
veliparib
3
aldesleukin
3
Trastuzumab
3
Specimen Handling
3
Nivolumab
3
Diathermy
3
Cytoreduction Surgical Procedures
3
sargramostim
2
entinostat
2
cemiplimab
2
cediranib
2
X-Rays
2
Therapeutics
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Metformin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
In Situ Hybridization, Fluorescence
×
Gynecologic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled